Literature DB >> 9046256

p53 regulates apoptosis in human retinoblastoma.

T M Nork1, G L Poulsen, L L Millecchia, R G Jantz, R W Nickells.   

Abstract

OBJECTIVES: To determine whether apoptosis is a significant mode of cell death in human retinoblastoma (RB) and if it is regulated by the expression of p53.
METHODS: Apoptosis was analyzed using the criterion of internucleosomal DNA degradation as determined by agarose gel electrophoresis of DNA isolated from tumor specimens. Individual cells undergoing apoptosis were identified using terminal transferase-mediated biotin-dUTP nick end labeling (TUNEL) of fragmented DNA. The expression of p53 and WAF1 (a protein involved in p53-mediated cell cycle arrest) in human RB was determined by immunocytochemical analysis. The function of p53 in human RB cell lines was tested by transfecting them with a complementary DNA encoding a temperature-sensitive isoform of murine p53 under the control of a strong viral promoter.
RESULTS: DNA from RB tumor specimens showed a strong nucleosomal ladder of DNA fragments typical of apoptosis. The TUNEL staining indicated that poorly and moderately differentiated cells in tumors were undergoing DNA fragmentation. Immunoreactivity for p53 was variable. Cells expressing low levels of p53 seemed viable and expressed WAF1. Cells expressing high levels of p53 were found immediately adjacent to cells undergoing apoptosis. Human RB cells in culture that were expressing a murine temperature-sensitive isoform of p53 died at temperatures that allow this protein to assume a wild-type conformation.
CONCLUSIONS: Apoptotic cell death is prevalent in RB. The close association of p53-immunoreactive cells and cells undergoing apoptosis in human tumors, and the ability of exogenous p53 to stimulate cell death in cultured human RB cells, suggests that p53 plays a role in regulating cell death in RB.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9046256     DOI: 10.1001/archopht.1997.01100150215011

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

1.  Distributions of p53 codon 72 polymorphism in primary open angle glaucoma.

Authors:  H-J Lin; W-C Chen; F-J Tsai; S-W Tsai
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

2.  Feasibility and effect of ultrasound microbubble-mediated wild-type p53 gene transfection of HeLa cells.

Authors:  Wen-Juan Chen; Zheng-Ai Xiong; Yan Tang; Pei-Ting Dong; Pan Li; Zhi-Gang Wang
Journal:  Exp Ther Med       Date:  2012-03-27       Impact factor: 2.447

3.  Childhood cancer and developmental biology a crucial partnership.

Authors:  Sara Federico; Rachel Brennan; Michael A Dyer
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

4.  Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.

Authors:  S E Coupland; N Bechrakis; A Schüler; I Anagnostopoulos; M Hummel; N Bornfeld; H Stein
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

5.  Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma.

Authors:  Ying Guo; Sanja Pajovic; Brenda L Gallie
Journal:  Biochem Biophys Res Commun       Date:  2008-07-21       Impact factor: 3.575

6.  The mouse double minute 2 309T>G polymorphism and retinoblastoma risk: A meta-analysis.

Authors:  K Sooraj; Sunil Kumar; Amit Kumar; Mandeep S Bajaj; Jasbir Kaur
Journal:  Saudi J Ophthalmol       Date:  2021-02-27

7.  Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma.

Authors:  Sushma Kalmodia; Sowmya Parameswaran; Kalaivani Ganapathy; Wenrong Yang; Colin J Barrow; Jagat R Kanwar; Kislay Roy; Madavan Vasudevan; Kirti Kulkarni; Sailaja V Elchuri; Subramanian Krishnakumar
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.